| Title |
Publication Date |
Price |
Drug Delivery in Cancer
Technologies, Markets and Companies
|
May 2009 |
£1830 |
DNA Sequencing
Technologies,Markets and Companies
|
May 2009 |
£610 |
Nitric Oxide
Therapeutics, Markets and Companies
|
May 2009 |
£1710 |
Cell Therapy
Technologies, Markets and Companies
|
May 2009 |
£2745 |
RNAi
Technologies, Markets and Companies
|
May 2009 |
£1830 |
6th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production
|
April 2009 |
£1030 |
A Quick Guide to Biotechnology and Healthcare in the Middle East
|
April 2009 |
£175 |
Biosimilars and Follow-On Biologics Report
The Global Outlook 2009-2024
|
April 2009 |
£1499 |
Biotechnology in Australia
IBISWorld Industry Report
|
April 2009 |
£360 |
Companion Biomarkers in Drug Development
|
April 2009 |
£2075 |
The Future of Biobanks
Regulation, ethics, investment and the humanization of drug discovery
|
March 2009 |
£2025 |
Bioinformatics Markets
Strategies, Business Models and Trends for the Future
|
March 2009 |
£2075 |
Biotechnology in the US
IBISWorld Industry Report
|
March 2009 |
£395 |
Strategic Analysis of U.S. MicroRNA Services Markets
|
March 2009 |
£3660 |
Biophotonics: A Strategic Assessment of Photonics Technologies for Biomedical Applications
2nd Edition
|
December 2008 |
£2435 |
Biologic Imaging Reagents
Technologies and Global Markets
|
December 2008 |
£1915 |
Top 10 Biotech Companies
Market Outlook, 2008-2023
|
December 2008 |
£1499 |
RNA Interference Markets
|
December 2008 |
£2075 |
Quality for Biologics
Critical quality attributes, process and change control, product variation, characterisation, and regulatory concerns
|
December 2008 |
£1495 |
MarketWatch: Biotechnology
|
November 2008 |
£105 |
Biopharmaceutical Expression Systems and Genetic Engineering Technologies
Current and Future Manufacturing Platforms
|
November 2008 |
£395 |
Biotechnology
Global Industry Guide
|
November 2008 |
£790 |
Stem Cells Come of Age
|
November 2008 |
£2290 |
Stem Cell Markets
|
October 2008 |
£2075 |
Future of RNAi Therapeutics, The
Drug Pipelines and Prospects
|
September 2008 |
£1995 |
U.S. Chemical and Biological Detection Markets
|
September 2008 |
£2375 |
Biosimilars: a viable market?
|
September 2008 |
£1295 |
U.S. Stem Cell Market - Current Development
|
September 2008 |
£2375 |
Directory of Top 60 Biopharmaceutical Manufacturers in INDIA
|
September 2008 |
£850 |
Biotechnology in the Netherlands
|
September 2008 |
£180 |
Biotechnology in Japan
|
September 2008 |
£180 |
Global Biotechnology
|
September 2008 |
£180 |
Biotechnology in Italy
|
September 2008 |
£180 |
Biotechnology in the United States
|
September 2008 |
£180 |
Biotechnology in the United Kingdom
|
September 2008 |
£180 |
Biotechnology in Spain
|
September 2008 |
£180 |
Biotechnology in China
|
September 2008 |
£180 |
Biotechnology in Belgium
|
September 2008 |
£180 |
Biotechnology in Europe
|
September 2008 |
£180 |
Biotechnology in Canada
|
September 2008 |
£180 |
Biotechnology in France
|
September 2008 |
£180 |
Biotechnology in Germany
|
September 2008 |
£180 |
Biotechnology in Asia-Pacific
|
September 2008 |
£180 |
Medical Nanotechnology Markets
|
September 2008 |
£2075 |
China Pharmaceutical & Biotechnology Monthly
(Single user, one year subscription)
|
September 2008 |
£1220 |
Microarray Markets
|
September 2008 |
£1220 |
Synthes Medical Device Company Intelligence Report
|
August 2008 |
£295 |
Practical Systems Biology
Demonstrating Value Today in Pharma R&D
|
August 2008 |
£915 |
Global Biotech Market Analysis and Forecasts, 2008-2023
|
August 2008 |
£1499 |
Xceed Biotechnology Limited - Healthcare - Medical Equipment
SWOT Report
|
August 2008 |
£76 |
Sutter Health - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£76 |
XCounter Ab - Healthcare - Medical Equipment
SWOT Report
|
August 2008 |
£76 |
Southern Cross Healthcare Group Plc - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£76 |
Spectrum Health System - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£76 |
LifePoint Hospitals, Inc. - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£76 |
Stille Ab - Healthcare - Medical Equipment
SWOT Report
|
August 2008 |
£76 |
Jefferson Health System, Inc. - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£76 |
Inova Health System - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£76 |
Hip Health Plan of New York - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£76 |
Mayo Foundation for Medical Education and Research - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£76 |
MedCath Corporation - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£76 |
Ramsay Health Care Limited - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£76 |
Providence Health System - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£76 |
NewYork- Presbyterian Hospital - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£76 |
New York City Health and Hospitals Corporation - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£76 |
Group Health Cooperative - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£76 |
Intermountain Healthcare, Inc. - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£76 |
Cml Healthcare Income Fund - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£76 |
Catholic Health Services of Long Island - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£76 |
Baylor Health Care System - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£76 |
Catholic Healthcare Partners - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£76 |
Sisters of Mercy Health System - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£76 |
Clarian Health Partners, Inc. - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£76 |
Christus Health - Healthcare - Managed Care and Hospitals
SWOT Report
|
August 2008 |
£76 |
Scanlan International Inc. Medical Equipment
Company Share Analysis
|
July 2008 |
£610 |
Schiller Ag Medical Equipment
Company Share Analysis
|
July 2008 |
£305 |
Karl Storz Gmbh & Co. Kg Medical Equipment
Company Share Analysis
|
July 2008 |
£610 |
Synergetics USA. Inc.Medical Equipment
Company Share Analysis
|
July 2008 |
£610 |
Medikro Oy. Medical Equipment
Company Share Analysis
|
July 2008 |
£610 |
Spectrum Surgical Instruments Corporation Medical Equipment
Company Share Analysis
|
July 2008 |
£610 |
Shofu Inc. Medical Equipment
Company Share Analysis
|
July 2008 |
£610 |
Ontex International N.V. Medical Equipment
Company Share Analysis
|
July 2008 |
£610 |
Biopharmaceuticals in South East Asia
|
July 2008 |
£795 |
Microscopy Markets
|
July 2008 |
£2075 |
DNA Sequencing and PCR Markets
|
July 2008 |
£2075 |
Barr Pharmaceuticals Generics Company Intelligence Report
|
June 2008 |
£195 |
Daiichi Sankyo: Pipeline, Products, Performance, Potential
|
June 2008 |
£595 |
Eisai Pipeline - Products - Performance - Potential
|
June 2008 |
£595 |
Dr Reddy's Laboratories Generics Company Intelligence Report
|
June 2008 |
£195 |
Mylan Laboratories Generics Company Intelligence Report
|
June 2008 |
£195 |
Teva Pharmaceutical Industries Generics Company Intelligence Report
|
June 2008 |
£195 |
Dr Reddy's Laboratories Generics Company Intelligence Report
|
June 2008 |
£195 |
SNP Genotyping and Analysis Markets
|
June 2008 |
£2435 |
Booming Biotech Market in India
|
June 2008 |
£430 |
Monoclonal Antibodies Report
|
June 2008 |
£3800 |
Shionogi
Pipeline, Products, Performance, Potential
|
April 2008 |
£595 |
Shionogi: Pipeline - Products - Performance - Potential
|
April 2008 |
£595 |
Boehringer Ingelheim: Pipeline, Products, Performance, Potential
|
April 2008 |
£595 |
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
|
April 2008 |
£2075 |
5th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production
A Study of Biotherapeutic Developers and Contract Manufacturing Organizations, 2007
|
April 2008 |
£970 |
Biogenerics, The World Market
Biosimilars and Follow-On Biologics at a Crossroads
|
April 2008 |
£2135 |
Fastest Growing Biotechnology Companies, The
Growth Strategies, Comparative Analyses and Company Profiles
|
March 2008 |
£1995 |
Somaxon Pharmaceuticals Inc
Premium Company Profile
|
March 2008 |
£265 |
Threshold Pharmaceuticals Inc
Premium Company Profile
|
March 2008 |
£265 |
MicroRNAs
Commercial Products on the Horizon
|
March 2008 |
£685 |
Indian Biotechnology Industry Report
|
March 2008 |
£400 |
Label Free Binding Analysis Trends 2008
|
March 2008 |
£1540 |
STERIS Corporation
Strategic Analysis Profile
|
February 2008 |
£34 |
Biosite Incorporated
Strategic Analysis Profile
|
February 2008 |
£480 |
Orthofix International N.V.
Strategic Analysis Profile
|
February 2008 |
£480 |
Philips Medical Systems
Strategic Analysis Profile
|
February 2008 |
£480 |
Nobel Biocare Holding AG
Strategic Analysis Profile
|
February 2008 |
£46 |
Luxottica Group S.p.A.
Strategic Analysis Profile
|
February 2008 |
£480 |
Kinetic Concepts, Inc.
Strategic Analysis Profile
|
February 2008 |
£34 |
Bayer Healthcare
Strategic Analysis Profile
|
February 2008 |
£480 |
C. R. Bard, Inc.
Strategic Analysis Profile
|
February 2008 |
£480 |
F. Hoffmann-La Roche Ltd.
Strategic Analysis Profile
|
February 2008 |
£480 |
Fresenius SE
Strategic Analysis Profile
|
February 2008 |
£480 |
Elekta AB
Strategic Analysis Profile
|
February 2008 |
£34 |
Edwards Lifesciences Corporation
Strategic Analysis Profile
|
February 2008 |
£34 |
DaVita Inc.
Strategic Analysis Profile
|
February 2008 |
£480 |
Datascope Corp.
Strategic Analysis Profile
|
February 2008 |
£34 |
Coloplast AS
Strategic Analysis Profile
|
February 2008 |
£480 |
Carl Zeiss Meditec AG
Strategic Analysis Profile
|
February 2008 |
£480 |
Invacare Corporation
Strategic Analysis Profile
|
February 2008 |
£480 |
KYOWA HAKKO KOGYO Co., Ltd.
Strategic Analysis Profile
|
February 2008 |
£480 |
IDEXX Laboratories, Inc.
Strategic Analysis Profile
|
February 2008 |
£480 |
Hanger Orthopedic Group, Inc.
Strategic Analysis Profile
|
February 2008 |
£34 |
Gyrus Group PLC
Strategic Analysis Profile
|
February 2008 |
£480 |
Haemonetics Corporation
Strategic Analysis Profile
|
February 2008 |
£34 |
DJO Incorporated
Strategic Analysis Profile
|
February 2008 |
£480 |
Alliance Imaging, Inc.
Strategic Analysis Profile
|
February 2008 |
£34 |
bioMerieux S.A.
Strategic Analysis Profile
|
February 2008 |
£480 |
Johnson & Johnson
Strategic Analysis Profile
|
February 2008 |
£480 |
ZOLL Medical Corporation
Strategic Analysis Profile
|
February 2008 |
£34 |
Wright Medical Group, Inc.
Strategic Analysis Profile
|
February 2008 |
£34 |
Wavelight AG check
Strategic Analysis Profile
|
February 2008 |
£480 |
Arrow International, Inc.
Strategic Analysis Profile
|
February 2008 |
£480 |
Ansell Limited
Strategic Analysis Profile
|
February 2008 |
£46 |
ABIOMED, Inc.
Strategic Analysis Profile
|
February 2008 |
£34 |
Accuray Incorporated
Strategic Analysis Profile
|
February 2008 |
£480 |
Air Liquide
Strategic Analysis Profile
|
February 2008 |
£34 |
B. Braun Melsungen AG
Strategic Analysis Profile
|
February 2008 |
£480 |
Sectra AB
Strategic Analysis Profile
|
February 2008 |
£34 |
Thoratic Corporation
Strategic Analysis Profile
|
February 2008 |
£480 |
Sorin S.p.A.
Strategic Analysis Profile
|
February 2008 |
£480 |
Thermo Fisher Scientific Inc.
Strategic Analysis Profile
|
February 2008 |
£34 |
SonoSite, Inc.
Strategic Analysis Profile
|
February 2008 |
£480 |
Smiths Medical
Strategic Analysis Profile
|
February 2008 |
£480 |
Siemens Medical Solutions
Strategic Analysis Profile
|
February 2008 |
£480 |
Straumann Holding AG
Strategic Analysis Profile
|
February 2008 |
£480 |
St. Jude Medical Inc.
Strategic Analysis Profile
|
February 2008 |
£480 |
Terumo Corporation
Strategic Analysis Profile
|
February 2008 |
£46 |
The Cooper Companies, Inc.
Strategic Analysis Profile
|
February 2008 |
£480 |
Symmetry Medical Inc.
Strategic Analysis Profile
|
February 2008 |
£34 |
Teleflex Incorporated
Strategic Analysis Profile
|
February 2008 |
£34 |
Synthes GmbH
Strategic Analysis Profile
|
February 2008 |
£480 |
Advances in Biopharmaceutical Technology in India
|
February 2008 |
£1995 |
Environmental Markets for Biotechnology
|
January 2008 |
£2960 |
China Molecular Diagnostics & Database Package
|
January 2008 |
£3050 |
Cell Based Label-Free Detection Trends 2007
|
January 2008 |
£1540 |
China Biotech 2008 & Database Package
|
January 2008 |
£305 |
Indian Biotechnology
|
January 2008 |
£600 |
Indian Biopharmaceuticals
|
January 2008 |
£600 |
Launching Combination Products
Brand Extension and Franchise Development Strategies
|
January 2008 |
£1995 |
Innovations in Bioinformatics
Emerging Tools for Drug Discovery and Development
|
January 2008 |
£1995 |
Antibiotics and Drug Resistance 2008
Drug Innovation and the Strategy to Combat - Antibiotic Resistance Mechanisms
|
January 2008 |
£1499 |
China Vaccine & Database Package
|
December 2007 |
£3050 |
TR-FRET Based Assay Trends 2008
|
December 2007 |
£1540 |
Immunogenicity to Biologics
Implications Of Reactions Against Biotech Drugs
|
November 2007 |
£1450 |
Premium Company Profile: Invitrogen Corporation
|
November 2007 |
£265 |
Premium Company Profile: BioMarin Pharmaceutical Inc.
|
November 2007 |
£265 |
Biomarkers
The Expanding Global Market
|
November 2007 |
£2960 |
RNAi Therapeutics 2008
|
November 2007 |
£2350 |
Biosimilars Series
Strategic Issues - Potential Remains Uncertain
|
October 2007 |
£2005 |
Pharmaceutical Biotechnology: Fundamentals and Applications
Third Edition
|
October 2007 |
£115 |
Building Pharmaceutical-Biotechnology Partnerships and Alliances
Market Preparation & Strategic Support
|
October 2007 |
£4270 |
Monoclonal Antibodies Report Part II
Companies - Holding Mabs In Portfolio Promises Protection Against The Looming 2011-12 Patent Cliff
|
September 2007 |
£3800 |
Global Biotechnology
IBISWorld Industry Report
|
September 2007 |
£460 |
Global Protein Therapeutics Market Analysis
|
September 2007 |
£1100 |
U.S. Bioethanol & Cellulosic Ethanol Market & Future Direction
|
September 2007 |
£670 |
Biopharmaceutical Products in the US and European Markets
6th Edition
|
September 2007 |
£910 |
Biomanufacturing Strategies
Market Drivers, Build-Vs-Buy Decisions And Opportunities In Contract Relationship Management
|
September 2007 |
£1495 |
World Enzymes
Study # 2229
|
September 2007 |
£3295 |
Stem Cells 2007-2008
|
September 2007 |
£2350 |
China Biotherapeutics Database 2006
|
September 2007 |
£1005 |
Microplate Mixing Trends 2007
|
September 2007 |
£1540 |
Biomet Medical Device Company Intelligence Report
|
August 2007 |
£395 |
Personalized Medicine
|
August 2007 |
£1220 |
Pigments: Inorganic, Organic & Specialty
|
August 2007 |
£1365 |
Global Biotechnology Industry 2006 - Power Point Presentation (Editable)
|
July 2007 |
£400 |
Top Companies and Products in the RNA/DNA Therapy Products Market Forecasts:
The Challenge Of Turning Technology Into Therapy
|
July 2007 |
£1999 |
Global Biotechnology -Yearly Update 2006
|
July 2007 |
£600 |
Company Study of Shanghai Kehua Bio-engineering Co.
Ltd., 2007
|
July 2007 |
£180 |
European Biotech Industry Guide 2007
5th Edition
|
July 2007 |
£515 |
Nanotoxicology: Characterization, Dosing and Health Effects
|
July 2007 |
£432 |
Monoclonal Antibodies Report Market Model
|
June 2007 |
£3800 |
Monoclonal Antibodies Report Part I
|
June 2007 |
£3800 |
Biomarkers and Tests for Pharma/ Biotech R&D
Companies, Products and Worldwide Market, 2006-2011
|
June 2007 |
£1585 |
Asia Pacific Biotechnology Market
2007-2010
|
June 2007 |
£975 |
Asia Pacific Biotechnology Market
2007-2010
|
June 2007 |
£485 |
Asia Pacific Biotechnology Market
2007-2010
|
June 2007 |
£485 |
DNA Sequencing Equipment and Services Markets
|
June 2007 |
£2440 |
Ion Channel Trends 2007
|
June 2007 |
£1540 |
BIOTECH 2007 Life Sciences
A Global Transformation
|
May 2007 |
£270 |
Cardiovascular Multidetector CT Angiography
|
May 2007 |
£99 |
Multi-Mode Microplate Reader Trends 2007
|
May 2007 |
£1540 |
Minimally Invasive Spine Surgery
|
May 2007 |
£145 |
Canadian Biotech News Industry Report
|
April 2007 |
£855 |
China Antibodies & Database Package
|
April 2007 |
£1220 |
High-Content Analysis 2007
|
April 2007 |
£1540 |
Becton-Dickinson Medical Device Company Intelligence Report
|
March 2007 |
£395 |
US Biotech Market Analysis
|
March 2007 |
£300 |
The Dynamic Media, Sera and Reagent Market in Biotechnology
|
March 2007 |
£2960 |
Biocompatible Materials for the Human Body
|
March 2007 |
£2960 |
Fluorescence Lifetime Trends 2007
|
March 2007 |
£1540 |
China Biopharmaceutical Industry Report, 2006-2007
|
March 2007 |
£180 |
Siemens Medical Solutions Medical Device Company Intelligence Report
|
February 2007 |
£395 |
Biotech Drug Delivery Systems
Key Company Intelligence & Market Outlook to 2012
|
February 2007 |
£1299 |
Bio/Chemical Sensors
The Bourne Report
|
February 2007 |
£425 |
Separation Systems for Commercial Biotechnology
|
February 2007 |
£2960 |
RNAi/MicroRNA 2007
|
February 2007 |
£2350 |
Biomarkers: A Market Briefing
A Market Briefing
|
January 2007 |
£1215 |
Stem Cells - The hype and the hope
Business opportunities and forecasts
|
January 2007 |
£4999 |
Analysis Report on Major Enterprises in the Chinese Bearing Industry
|
January 2007 |
£185 |
Genetically Modified Crops
Industry Report
|
January 2007 |
£400 |
Indian Biopharmaceuticals Industry Report
|
January 2007 |
£400 |
A Guide to Biosimilars, Biogenerics and Follow-on Biologics
|
January 2007 |
£1095 |
Scrip's Pharmaceutical Company League Tables 2007
|
January 2007 |
£1870 |
Microplate Instrument Trends 2007
|
January 2007 |
£1540 |
Cell Culture
The World Market for Media, Sera, and Reagents
|
January 2007 |
£2380 |
Market for Bioengineered Protein Drugs; The
|
January 2007 |
£2960 |
The China Pharmaceutical Market: A Strategic Opportunity Analysis
|
January 2007 |
£840 |
Clinica's Guide to Early-stage Medtech Companies
|
January 2007 |
£500 |
Applied Biosystems Group
|
December 2006 |
£185 |
Biosimilars: Benchmarking the key players
With increasing regulatory clarity and high revenue potential, interest in biosimilars increases
|
December 2006 |
£4000 |
Biosimilars: Regulatory Issues
Europe continues to make strides while the US lags behind
|
December 2006 |
£2005 |
Biotechnology: Global Industry Guide
|
December 2006 |
£530 |
Biopartnering Strategies
Maximizing returns from biotechnology deal-making
|
December 2006 |
£1495 |
Global Market for Antimicrobials and Antifungals; The
Challenging Resistance to 2016
|
December 2006 |
£1600 |
Next Generation Battery
U.S. Biofuel Cells R&D and Future Directions
|
October 2006 |
£800 |
Advances in Biopharmaceutical Technology in China
|
September 2006 |
£3410 |
Biocompatible Materials
US industry forecasts to 2010 & 2015
|
September 2006 |
£2685 |
Chinese Markets for Biotechnology
|
August 2006 |
£2440 |
China Industrial Biotechnology
|
August 2006 |
£2440 |
Commercial Insight: Antidyslipidemics
Branded statins beware, generics are amongst you
|
July 2006 |
£8440 |
Protein and Antibody Microarrays Markets
Sector Snapshot
|
July 2006 |
£305 |
Global Biotechnology Industry 2006
|
June 2006 |
£550 |
Future of BioSciences; The
Four Scenarios for 2020 and Their Implications for Human Healthcare
|
June 2006 |
£915 |
In Silico ADME/Tox Products Market 2006
|
June 2006 |
£1540 |
Automated Low Volume Dispensing Trends 2006
|
June 2006 |
£1540 |
Biotech 2010
|
June 2006 |
£2960 |
Biotech in Autoimmune and Inflammatory Disease 2006
2nd Edition
|
May 2006 |
£1830 |
China Bio-services & Database Package
|
May 2006 |
£1220 |
BioChips & BioMEMS (Bio Microelectromechanical Systems) World Markets, Applications & Opportunities
2006-2011 Analysis & Forecasts
|
May 2006 |
£1095 |
Medical and Biological Sensors and Sensor Systems
Markets, Applications, and Competitors Worldwide, 2nd Edition
|
May 2006 |
£2135 |
Executive Summary of the BioChips & BioMEMS (Biomedical Microelectromechanical Systems) Markets
2006-2011 Analysis & Forecasts
|
May 2006 |
£670 |
India: Pharmaceutical and biotechnology opportunities
|
April 2006 |
£840 |
Labeling and Linkage Agents for Immunoassays and Gene Probes
|
April 2006 |
£2960 |
Label Free Detection Trends 2006
|
April 2006 |
£1540 |
Outlook 2007
|
January 2006 |
£895 |
Clinica's Indian Market Briefing
|
January 2006 |
£500 |
Scrip Yearbook 2007
23rd Edition (2 Volumes)
|
January 2006 |
£895 |
Clinica's Medical Device and Diagnostic Company League Tables 2006
|
January 2006 |
£1095 |
Indian Biodiesel
Industry Report
|
January 2006 |
£400 |
HCS Imaging Trends
|
November 2005 |
£1540 |
Stem Cells: Industry Background Report
List of Companies
|
October 2005 |
£295 |
Gene Therapy: Industry Background Report
List of Companies
|
October 2005 |
£345 |
Protein expression: Industry Background Report
List of Companies
|
October 2005 |
£295 |
SNPs: Industry Background Report
List of Companies
|
October 2005 |
£295 |
Biomaterials: Industry Background Report
|
October 2005 |
£235 |
Biomarkers: Industry Background Report
List of Companies
|
October 2005 |
£295 |
Micro-Arrays: Industry Background Report
List of Companies
|
October 2005 |
£345 |
Monoclonal Antibodies: Industry Background Report
List of Companies
|
October 2005 |
£400 |
Proteomics: Industry Background Report
List of Companies
|
October 2005 |
£400 |
Bioinformatics: Industry Background Report
List of Companies
|
October 2005 |
£345 |
DNA Sequencing: Industry Background Report
List of Companies
|
October 2005 |
£345 |
High Content, Cell-Based Analysis
Industry Background Report
|
October 2005 |
£345 |
Modern Biopharmaceuticals
Design, Development and Optimization, 4 Volumes
|
September 2005 |
£440 |
Protein Microarrays: Technology Adoption & Utilization
Technology Adoption & Utilization
|
September 2005 |
£2745 |
Dynamic Antibody Industry
|
August 2005 |
£2960 |
Market for DNA Microarrays; The
Core Lab & End-User Perspectives
|
August 2005 |
£2195 |
Bioinformatics
Technical Status and Market Prospects
|
August 2005 |
£2960 |
Biotech Equipment Update: June 2005
|
June 2005 |
£17 |
Worldwide Biotech
June 2005
|
June 2005 |
£17 |
Biotech Business: June 2005
|
June 2005 |
£17 |
Biotech Financial Reports: June 2005
|
June 2005 |
£17 |
Handbook of Genome Research
Genomics, Proteomics, Metabolomics, Bioinformatics, Ethical and Legal Issues, Two Volumes
|
June 2005 |
£175 |
Cell Culture: The World Market for Media, Sera and Reagents
2nd Edition
|
May 2005 |
£2435 |
Biotech Equipment Update: May 2005
|
May 2005 |
£17 |
Biotech Business: May 2005
|
May 2005 |
£17 |
Biotech Financial Reports: May 2005
|
May 2005 |
£17 |
Worldwide Biotech: May 2005
|
May 2005 |
£17 |
Biotech Equipment Update: March 2005
|
March 2005 |
£17 |
Biotech Business: March 2005
|
March 2005 |
£17 |
Biotech Financial Reports: March 2005
|
March 2005 |
£17 |
Worldwide Biotech: March 2005
|
March 2005 |
£17 |
Biotech Equipment Update: February 2005
|
February 2005 |
£17 |
Biotech Financial Reports: February 2005
|
February 2005 |
£17 |
Worldwide Biotech: February 2005
|
February 2005 |
£17 |
Biotech Business: February 2005
|
January 2005 |
£17 |
Bioinformatics
A Practical Guide to the Analysis of Genes and Proteins, 3rd Edition
|
November 2004 |
£50.95 |
Biostatistics: A Methodology For the Health Sciences
2nd Edition
|
August 2004 |
£73.5 |
Race to Commercialize Biotechnology, The
Molecules, Market and the State in Japan and the US
|
March 2004 |
£80 |
Pharmaceutical Biotechnology
Drug Discovery and Clinical Applications
|
February 2004 |
£115 |
Nanotubes Report 2004, The
|
January 2004 |
£1730 |
Nanoparticles
|
October 2003 |
£375 |
Biopharmaceuticals: Biochemistry and Biotechnology
Second Edition
|
July 2003 |
£47.5 |
Biotechnology and Biopharmaceuticals
Transforming Proteins and Genes into Drugs
|
July 2003 |
£55.95 |
Nanotechnology Opportunity Report, The
|
June 2003 |
£1330 |
Medical and Pharmaceutical Market Opportunities
|
June 2003 |
£300 |
Technimanagement: The Human Side of the Organization
|
December 1999 |
£82 |
